| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |